{
  "url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2017/article-4",
  "json_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2017/article-4.json",
  "legislation": "ukdsi/2017/9780111156346",
  "legislation_title": "The Misuse of Drugs Act 1971 (Amendment) Order 2017",
  "legislation_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2017",
  "path": "article/4",
  "kind": "article",
  "number": "4",
  "heading": "Amendments to the Misuse of Drugs Act 1971",
  "text": "In paragraph 1(a) of Part 2 (which specifies the drugs which are subject to control under that Act as Class B drugs)—\n(a) after “Amphetamine.” insert—\n“N-Benzyl-ethylphenidate.”;\n(b) after “Ethylmorphine (3-ethylmorphine).” insert—\n“Ethylnaphthidate.\nEthylphenidate.”;\n(c) after “Glutethimide.” insert—\n“Isopropylphenidate (IPP or IPPD).”;\n(d) after “Methcathinone.” insert—\n“Methylmorphenate.”\n“Methylnaphthidate (HDMP-28).”;\n(e) after “Propiram.” insert—\n“Propylphenidate.”;\n(f) after “Zipeprol.” insert—\n“3,4-Dichloroethylphenidate.”\n“3,4-Dichloromethylphenidate (3,4-DCMP).”;\n(g) after “2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol” insert—\n“4-Fluoroethylphenidate.”\n“4-Fluoromethylphenidate.”\n“4-Methylmethylphenidate.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2017/9780111156346/article/4",
    "retrieved_at": "2026-10-30T15:06:34.330007+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}